Experience with replacement therapy in the destructive lung disease associated with severe alpha-1-antitrypsin deficiency.
D006801:Humans; D007263:Infusions, Parenteral; D010641:Phenotype; D011656:Pulmonary Emphysema / Q000188:drug therapy / Q000628:therapy*; D000515:alpha 1-Antitrypsin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D019896:alpha 1-Antitrypsin Deficiency
D000515:alpha 1-Antitrypsin